Johannes Zuber (J Zuber)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 42

Top Venues

Nature communications

eLife

Blood

Science (New York, N.Y.)

Research Institute of Molecular Pathology (IMP)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Research Institute of Molecular Pathology (IMP) Jan 01 2020

Austria

Senior Scientist

Medical University of Vienna Sep 19 2017

Austria

Adjunct Professor

Research Institute of Molecular Pathology (IMP)

Austria

Group Leader / PI :: Zuberlab

Cold Spring Harbor Laboratory

United States

Clinical Research Fellow :: Scott Lowe Lab

Cold Spring Harbor Laboratory

United States

Postdoc :: Scott Lowe Lab

Charite Universitatsmedizin Berlin Campus Virchow-Klinikum

Germany

Resident MD :: Hematology / Oncology

Publications

Chrysanthi Kagiou, Jose A Cisneros, Jakob Farnung, Joanna Liwocha, Fabian Offensperger, Kevin Dong, Ka Yang, Gary Tin, Christina S Horstmann, Matthias Hinterndorfer, Joao A Paulo, Natalie S Scholes, Juan Sanchez Avila, Michaela Fellner, Florian Andersch, J Thomas Hannich, Johannes Zuber, Stefan Kubicek, Steven P Gygi, Brenda A Schulman, Georg E Winter
Alkylamine-tethered molecules recruit FBXO22 for targeted protein degradation. Nature communications 15 (1) (2024)
Georg Greiner, Nadine Witzeneder, Klara Klein, Simone Tangermann, Petra Kodajova, Eva Jaeger, Franz Ratzinger, Marlene C Gerner, Mohamad Jawhar, Sigrid Baumgartner, Karin Fruehwirth, Klaus Georg Schmetterer, Johannes Zuber, Karoline V Gleixner, Matthias Mayerhofer, Ilse Schwarzinger, Ingrid Simonitsch-Klupp, Harald Esterbauer, Constance Baer, Wencke Walter, Manja Meggendorfer, Robert Strassl, Torsten Haferlach, Karin Hartmann, Lukas Kenner, Wolfgang R Sperr, Andreas Reiter, Veronika Sexl, Michel Arock, Peter Valent, Gregor Hoermann
Tumor necrosis factor α promotes clonal dominance of KIT D816V+ cells in mastocytosis: role of survivin and impact on prognosis. Blood 143 (11) (2024)
Chrysanthi Kagiou, Jose A Cisneros, Jakob Farnung, Joanna Liwocha, Fabian Offensperger, Kevin Dong, Ka Yang, Gary Tin, Christina S Horstmann, Matthias Hinterndorfer, Joao A Paulo, Natalie S Scholes, Juan Sanchez Avila, Michaela Fellner, Florian Andersch, J Thomas Hannich, Johannes Zuber, Stefan Kubicek, Steven P Gygi, Brenda A Schulman, Georg E Winter
Alkylamine-tethered molecules recruit FBXO22 for targeted protein degradation. Nature communications 15 (1) (2024)
Georg Greiner, Nadine Witzeneder, Klara Klein, Simone Tangermann, Petra Kodajova, Eva Jaeger, Franz Ratzinger, Marlene C Gerner, Mohamad Jawhar, Sigrid Baumgartner, Karin Fruehwirth, Klaus Georg Schmetterer, Johannes Zuber, Karoline V Gleixner, Matthias Mayerhofer, Ilse Schwarzinger, Ingrid Simonitsch-Klupp, Harald Esterbauer, Constance Baer, Wencke Walter, Manja Meggendorfer, Robert Strassl, Torsten Haferlach, Karin Hartmann, Lukas Kenner, Wolfgang R Sperr, Andreas Reiter, Veronika Sexl, Michel Arock, Peter Valent, Gregor Hoermann
Tumor necrosis factor α promotes clonal dominance of KIT D816V+ cells in mastocytosis: role of survivin and impact on prognosis. Blood 143 (11) (2024)
Chrysanthi Kagiou, Jose A Cisneros, Jakob Farnung, Joanna Liwocha, Fabian Offensperger, Kevin Dong, Ka Yang, Gary Tin, Christina S Horstmann, Matthias Hinterndorfer, Joao A Paulo, Natalie S Scholes, Juan Sanchez Avila, Michaela Fellner, Florian Andersch, J Thomas Hannich, Johannes Zuber, Stefan Kubicek, Steven P Gygi, Brenda A Schulman, Georg E Winter
Alkylamine-tethered molecules recruit FBXO22 for targeted protein degradation. Nature communications 15 (1) (2024)
Chrysanthi Kagiou, Jose A Cisneros, Jakob Farnung, Joanna Liwocha, Fabian Offensperger, Kevin Dong, Ka Yang, Gary Tin, Christina S Horstmann, Matthias Hinterndorfer, Joao A Paulo, Natalie S Scholes, Juan Sanchez Avila, Michaela Fellner, Florian Andersch, J Thomas Hannich, Johannes Zuber, Stefan Kubicek, Steven P Gygi, Brenda A Schulman, Georg E Winter
Alkylamine-tethered molecules recruit FBXO22 for targeted protein degradation. Nature communications 15 (1) (2024)
Sara Scinicariello, Adrian Soderholm, Markus Schäfer, Alexandra Shulkina, Irene Schwartz, Kathrin Hacker, Rebeca Gogova, Robert Kalis, Kimon Froussios, Valentina Budroni, Annika Bestehorn, Tim Clausen, Pavel Kovarik, Johannes Zuber, Gijs A Versteeg
HUWE1 controls tristetraprolin proteasomal degradation by regulating its phosphorylation. eLife 12 (2023)
Jessica Ebner, Johannes Schmoellerl, Martin Piontek, Gabriele Manhart, Selina Troester, Bing Z Carter, Heidi A Neubauer, Richard H Moriggl, Gergely Szakács, Johannes Zuber, Thomas Köcher, Michael Andreeff, Wolfgang R Sperr, Peter Valent, Florian Grebien
ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemia. Nature communications 14 (1) (2023)
Sara Scinicariello, Adrian Soderholm, Markus Schäfer, Alexandra Shulkina, Irene Schwartz, Kathrin Hacker, Rebeca Gogova, Robert Kalis, Kimon Froussios, Valentina Budroni, Annika Bestehorn, Tim Clausen, Pavel Kovarik, Johannes Zuber, Gijs A Versteeg
HUWE1 controls tristetraprolin proteasomal degradation by regulating its phosphorylation. eLife 12 (2023)
Thomas Hoffmann, Alexandra Hörmann, Maja Corcokovic, Jakub Zmajkovic, Matthias Hinterndorfer, Jasko Salkanovic, Fiona Spreitzer, Anna Köferle, Katrin Gitschtaler, Alexandra Popa, Sarah Oberndorfer, Florian Andersch, Markus Schaefer, Michaela Fellner, Nicole Budano, Jan G Ruppert, Paolo Chetta, Melanie Wurm, Johannes Zuber, Ralph A Neumuller
Precision RNAi using synthetic shRNAmir target sites. eLife 12 (2023)
Irene Schwartz, Milica Vunjak, Valentina Budroni, Adriana Cantoran García, Marialaura Mastrovito, Adrian Soderholm, Matthias Hinterndorfer, Melanie de Almeida, Kathrin Hacker, Jingkui Wang, Kimon Froussios, Julian Jude, Thomas Decker, Johannes Zuber, Gijs A Versteeg
SPOP targets the immune transcription factor IRF1 for proteasomal degradation. eLife 12 (2023)
Alicia K Michael, Lisa Stoos, Priya Crosby, Nikolas Eggers, Xinyu Y Nie, Kristina Makasheva, Martina Minnich, Kelly L Healy, Joscha Weiss, Georg Kempf, Simone Cavadini, Lukas Kater, Jan Seebacher, Luca Vecchia, Deyasini Chakraborty, Luke Isbel, Ralph S Grand, Florian Andersch, Jennifer L Fribourgh, Dirk Schübeler, Johannes Zuber, Andrew C Liu, Peter B Becker, Beat Fierz, Carrie L Partch, Jerome S Menet, Nicolas H Thomä
Cooperation between bHLH transcription factors and histones for DNA access. Nature (2023)
Georg Greiner, Nadine Witzeneder, Klara Klein, Simone Tangermann, Petra Kodajova, Eva Jaeger, Franz Ratzinger, Marlene C Gerner, Mohamad Jawhar, Sigrid Baumgartner, Karin Fruehwirth, Klaus Georg Schmetterer, Johannes Zuber, Karoline V Gleixner, Matthias Mayerhofer, Ilse Schwarzinger, Ingrid Simonitsch-Klupp, Harald Esterbauer, Constance Baer, Wencke Walter, Manja Meggendorfer, Robert Strassl, Torsten Haferlach, Karin Hartmann, Lukas Kenner, Wolfgang R Sperr, Andreas Reiter, Veronika Sexl, Michel Arock, Peter Valent, Gregor Hoermann
TNF alpha promotes clonal dominance of KIT D816V+ cells in mastocytosis: role of survivin and impact on prognosis. Blood (2023)
Giovanni Ciriello, Luca Magnani, Sarah J Aitken, Leila Akkari, Sam Behjati, Douglas Hanahan, Dan A Landau, Núria López-Bigas, Darío G Lupiáñez, Jean-Christophe Marine, Ana Martin-Villalba, Gioacchino Natoli, Anna C Obenauf, Elisa Oricchio, Paola Scaffidi, Andrea Sottoriva, Alexander Swarbrick, Giovanni Tonon, Sakari Vanharanta, Johannes Zuber
Cancer Evolution: A Multifaceted Affair. Cancer discovery (2023)
Eitan Kugler, Shreyas Madiwale, Darren Yong, Julie A I Thoms, Yehudit Birger, David Brian Sykes, Johannes Schmoellerl, Aneta Drakul, Valdemar Priebe, Muhammad Yassin, Nasma Aqaqe, Avigail Rein, Hila Fishman, Ifat Geron, Chun-Wei David Chen, Brian Raught, Qiao Liu, Heather Ogana, Elisabeth Liedke, Jean-Pierre Bourquin, Johannes Zuber, Michael Milyavsky, John E Pimanda, Gilbert G Privé, Shai Izraeli
The NCOR-HDAC3 co-repressive complex modulates the leukemogenic potential of the transcription factor ERG. Nature communications 14 (1) (2023)
Stefan Butz, Nina Schmolka, Ino D Karemaker, Rodrigo Villaseñor, Isabel Schwarz, Silvia Domcke, Esther C H Uijttewaal, Julian Jude, Florian Lienert, Arnaud R Krebs, Nathalie P de Wagenaar, Xue Bao, Johannes Zuber, Ulrich Elling, Dirk Schübeler, Tuncay Baubec
DNA sequence and chromatin modifiers cooperate to confer epigenetic bistability at imprinting control regions. Nature genetics 54 (11) (2022)
Birgit Wilding, Dirk Scharn, Dietrich Böse, Anke Baum, Valeria Santoro, Paolo Chetta, Renate Schnitzer, Dana A Botesteanu, Christoph Reiser, Stefan Kornigg, Petr Knesl, Alexandra Hörmann, Anna Köferle, Maja Corcokovic, Simone Lieb, Guido Scholz, Jens Bruchhaus, Markus Spina, Josef Balla, Biljana Peric-Simov, Jasmin Zimmer, Sophie Mitzner, Thomas N Fett, Alexandra Beran, Lyne Lamarre, Thomas Gerstberger, Daniel Gerlach, Markus Bauer, Andreas Bergner, Andreas Schlattl, Gerd Bader, Matthias Treu, Harald Engelhardt, Stephan Zahn, Julian E Fuchs, Johannes Zuber, Peter Ettmayer, Mark Pearson, Mark Petronczki, Norbert Kraut, Darryl B McConnell, Flavio Solca, Ralph A Neumuller
Discovery of potent and selective HER2 inhibitors with efficacy against HER2 exon 20 insertion-driven tumors, which preserve wild-type EGFR signaling. Nature cancer 3 (7) (2022)
Barbara Peter, Gregor Eisenwort, Irina Sadovnik, Karin Bauer, Michael Willmann, Thomas Rülicke, Daniela Berger, Gabriele Stefanzl, Georg Greiner, Gregor Hoermann, Alexandra Keller, Dominik Wolf, Martin Čulen, Georg E Winter, Thomas Hoffmann, Ana-Iris Schiefer, Wolfgang R Sperr, Johannes Zuber, Jiří Mayer, Peter Valent
BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph + chronic myeloid leukemia. American journal of hematology 97 (9) (2022)
Catarina Pechincha, Sven Groessl, Robert Kalis, Melanie de Almeida, Andrea Zanotti, Marten Wittmann, Martin Schneider, Rafael Paschoal de Campos, Sarah Rieser, Marlene Brandstetter, Alexander Schleiffer, Karin Müller-Decker, Dominic Helm, Sabrina Jabs, David Haselbach, Marius K Lemberg, Johannes Zuber, Wilhelm Palm
Lysosomal enzyme trafficking factor LYSET enables nutritional usage of extracellular proteins. Science (New York, N.Y.) 378 (6615) (2022)
Melanie de Almeida, Matthias Hinterndorfer, Hanna Brunner, Irina Grishkovskaya, Kashish Singh, Alexander Schleiffer, Julian Jude, Sumit Deswal, Robert Kalis, Milica Vunjak, Thomas Lendl, Richard Imre, Elisabeth Roitinger, Tobias Neumann, Susanne Kandolf, Michael Schutzbier, Karl Mechtler, Gijs A Versteeg, David Haselbach, Johannes Zuber
AKIRIN2 controls the nuclear import of proteasomes in vertebrates. Nature 599 (7885) (2021)
Lisa Haas, Anais Elewaut, Camille L Gerard, Christian Umkehrer, Lukas Leiendecker, Malin Pedersen, Izabela Krecioch, David Hoffmann, Maria Novatchkova, Mario Kuttke, Tobias Neumann, Ines Pires da Silva, Harriet Witthock, Michel A Cuendet, Sebastian Carotta, Kevin J Harrington, Johannes Zuber, Richard A Scolyer, Georgina V Long, James S Wilmott, Olivier Michielin, Sakari Vanharanta, Thomas Wiesner, Anna C Obenauf
Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma. Nature cancer 2 (7) (2021)
Jeannine Diesch, Marguerite-Marie Le Pannérer, René Winkler, Raquel Casquero, Matthias Muhar, Mark van der Garde, Michael Maher, Carolina Martínez Herráez, Joan J Bech-Serra, Michaela Fellner, Philipp Rathert, Nigel Brooks, Lurdes Zamora, Antonio Gentilella, Carolina de la Torre, Johannes Zuber, Katharina S Götze, Marcus Buschbeck
Inhibition of CBP synergizes with the RNA-dependent mechanisms of Azacitidine by limiting protein synthesis. Nature communications 12 (1) (2021)
Emiel van der Kouwe, G Heller, A Czibere, John Anto Pulikkan, C Agreiter, Lucio H Castilla, R Delwel, Annalisa Di Ruscio, A K Ebralidze, M Forte, Florian Grebien, E Heyes, L Kazianka, J Klinger, Christoph Kornauth, T Le, K Lind, Inês A M Barbosa, Tea Pemovska, A Pichler, A-S Schmolke, C M Schweicker, H Sill, W R Sperr, A Spittler, S Surapally, B Q Trinh, Peter Valent, K Vanura, R S Welner, Johannes Zuber, D G Tenen, Philipp Bernhard Staber
Core-binding factor leukemia hijacks the T-cell-prone PU.1 antisense promoter. Blood 138 (15) (2021)
Jana Lasser, Johannes Zuber, Johannes Sorger, Elma Dervić, Katharina Ledebur, Simon David Lindner, Elisabeth Klager, Maria Kletecka-Pulker, Harald Willschke, Katrin Stangl, Sarah Stadtmann, Christian Haslinger, Peter Klimek, Thomas Wochele-Thoma
Agent-based simulations for protecting nursing homes with prevention and vaccination strategies. Journal of the Royal Society, Interface 18 (185) (2021)
Jorge A Zepeda-Martínez, C Pribitzer, Jingkui Wang, Daniel Bsteh, S Golumbeanu, Qing Zhao, Thomas Rainer Burkard, B Reichholf, Suhn Kyong Rhie, Julian Jude, Hagar F Moussa, Johannes Zuber, Oliver Bell
Parallel PRC2/cPRC1 and vPRC1 pathways silence lineage-specific genes and maintain self-renewal in mouse embryonic stem cells. Science advances 6 (14) (2020)
Christian Umkehrer, Felix Holstein, Laura Formenti, Julian Jude, Kimon Froussios, Tobias Neumann, Shona M Cronin, Lisa Haas, Jesse J Lipp, Thomas Rainer Burkard, Michaela Fellner, Thomas Wiesner, Johannes Zuber, Anna C Obenauf
Isolating live cell clones from barcoded populations using CRISPRa-inducible reporters. Nature biotechnology 39 (2) (2020)
Georg Michlits, Julian Jude, Matthias Hinterndorfer, Melanie de Almeida, Gintautas Vainorius, Maria Hubmann, Tobias Neumann, Alexander Schleiffer, Thomas Rainer Burkard, Michaela Fellner, Max Gijsbertsen, Anna Traunbauer, Johannes Zuber, Ulrich Elling
Multilayered VBC score predicts sgRNAs that efficiently generate loss-of-function alleles. Nature methods 17 (7) (2020)
Cristina Mayor-Ruiz, Sophie Bauer, Matthias Brand, Zuzanna Kozicka, Marton Siklos, Hana Imrichova, Ines H Kaltheuner, Elisa Hahn, Kristina Seiler, Anna Koren, Georg Petzold, Michaela Fellner, Christoph Bock, André C Müller, Johannes Zuber, Matthias Geyer, Nicolas H Thomä, Stefan Kubicek, Georg E Winter
Rational discovery of molecular glue degraders via scalable chemical profiling. Nature chemical biology 16 (11) (2020)
Christopher Esk, Dominik Lindenhofer, Simon Haendeler, Roelof A Wester, Florian G Pflug, Benoit Schroeder, Joshua Adam Bagley, Ulrich Elling, Johannes Zuber, Arndt von Haeseler, Jürgen Arthur Knoblich
A human tissue screen identifies a regulator of ER secretion as a brain-size determinant. Science (New York, N.Y.) 370 (6519) (2020)
Binbin Wang, Mei Wang, Wubing Zhang, Tengfei Xiao, Chen-Hao Chen, Alexander Wu, Feizhen Wu, Nicole Traugh, Xiaoqing Wang, Ziyi Li, Shenglin Mei, Yingbo Cui, Sailing Shi, Jesse Jonathan Lipp, Matthias Hinterndorfer, Johannes Zuber, Myles Brown, Wei Li, X Shirley Liu
Integrative analysis of pooled CRISPR genetic screens using MAGeCKFlute. Nature protocols 14 (3) (2019)
Wayo Matsushima, Veronika A Herzog, Tobias Neumann, Katharina Gapp, Johannes Zuber, Stefan L Ameres, Eric Alexander Miska
Sequencing cell-type-specific transcriptomes with SLAM-ITseq. Nature protocols 14 (8) (2019)
Sara Sdelci, André Figueiredo Rendeiro, Philipp Rathert, Wanhui You, Jung-Ming G Lin, Anna Ringler, Gerald Hofstätter, Herwig P Moll, Bettina Gürtl, Matthias Farlik, Sandra Schick, Freya Klepsch, Matthew Oldach, Pisanu Buphamalai, Fiorella Schischlik, Peter Májek, Katja Parapatics, Christian Schmidl, Michael K Schuster, Thomas Penz, Dennis L Buckley, Otto Hudecz, Richard Imre, Shuang-Yan Wang, Hans Michael Maric, Robert Kralovics, Keiryn L Bennett, Andre C Müller, Karl Mechtler, J Formula See Text Rg Menche, James E Bradner, Georg E Winter, Kristaps Klavins, Emilio Casanova, Christoph Bock, Johannes Zuber, Stefan Kubicek
MTHFD1 interaction with BRD4 links folate metabolism to transcriptional regulation. Nature genetics 51 (6) (2019)
Chi Huu Nguyen, Katharina Bauer, Hubert Hackl, Angela Schlerka, Elisabeth Koller, Anastasiya Hladik, Dagmar Stoiber, Johannes Zuber, Philipp B Staber, Andrea Hoelbl-Kovacic, Louise E Purton, Florian Grebien, Rotraud Wieser
All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemia. Cell death & disease 10 (12) (2019)
Petra Ebner, Isabella Poetsch, Luiza Deszcz, Thomas Hoffmann, Johannes Zuber, Fumiyo Ikeda
The IAP family member BRUCE regulates autophagosome-lysosome fusion. Nature communications 9 (1) (2018)
Matthias Muhar, Anja Ebert, Tobias Neumann, Christian Umkehrer, Julian Jude, Corinna Wieshofer, Philipp Rescheneder, Jesse J Lipp, Veronika A Herzog, Brian Reichholf, David A Cisneros, Thomas Hoffmann, Moritz F Schlapansky, Pooja Bhat, Arndt von Haeseler, Thomas Köcher, Anna C Obenauf, Johannes Popow, Stefan L Ameres, Johannes Zuber
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis. Science (New York, N.Y.) 360 (6390) (2018)
Daniel Gerlach, Ulrike Tontsch-Grunt, Anke Baum, Johannes Popow, Dirk Scharn, Marco H Hofmann, Harald Engelhardt, Onur Kaya, Janina Beck, Norbert Schweifer, Thomas Gerstberger, Johannes Zuber, Fabio Savarese, Norbert Kraut
The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AML. Oncogene 37 (20) (2018)
Anna Skucha, Jessica Ebner, Johannes Schmöllerl, Mareike Roth, Thomas Eder, Adrián César-Razquin, Alexey Stukalov, Sarah Vittori, Matthias Muhar, Bin Lu, Martin Aichinger, Julian Jude, André C Müller, Balázs Győrffy, Christopher R Vakoc, Peter Valent, Keiryn L Bennett, Johannes Zuber, Giulio Superti-Furga, Florian Grebien
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity. Nature communications 9 (1) (2018)
B Peter, S Bibi, G Eisenwort, B Wingelhofer, D Berger, G Stefanzl, K Blatt, H Herrmann, Emir Hadzijusufovic, G Hoermann, T Hoffmann, J Schwaab, M Jawhar, M Willmann, W R Sperr, Johannes Zuber, K Sotlar, H-P Horny, Richard H Moriggl, A Reiter, M Arock, P Valent
Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells. Leukemia 32 (4) (2017)
Nadine Hein, Donald P Cameron, Katherine M Hannan, Nhu-Y N Nguyen, Chun Yew Fong, Jirawas Sornkom, Meaghan Wall, Megan Pavy, Carleen Cullinane, Jeannine Diesch, Jennifer R Devlin, Amee J George, Elaine Sanij, Jaclyn Quin, Gretchen Poortinga, Inge Verbrugge, Adele Baker, Denis Drygin, Simon James Harrison, James D Rozario, Jason A Powell, Stuart M Pitson, Johannes Zuber, Ricky W Johnstone, Mark A Dawson, Mark A Guthridge, Andrew Wei, Grant A McArthur, Richard B Pearson, Ross D Hannan
Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population. Blood 129 (21) (2017)
M Joaquina Delás, Leah R Sabin, Egor Dolzhenko, Simon Rv Knott, Ester Munera Maravilla, Benjamin T Jackson, Sophia A Wild, Tatjana Kovacevic, Eva Maria Stork, Meng Zhou, Nicolas Erard, Emily Lee, David R Kelley, Mareike Roth, Inês Am Barbosa, Johannes Zuber, John L Rinn, Andrew D Smith, Gregory James Hannon
lncRNA requirements for mouse acute myeloid leukemia and normal differentiation. eLife 6 (2017)
Petra van der Lelij, Simone Lieb, Julian Jude, Gordana Wutz, Catarina P Santos, Katrina Falkenberg, Andreas Schlattl, Jozef Ban, Raphaela Schwentner, Thomas Hoffmann, Heinrich Kovar, Francisco X Real, Todd Waldman, Mark A Pearson, Norbert Kraut, Jan-Michael Peters, Johannes Zuber, Mark Petronczki
Synthetic lethality between the cohesin subunits STAG1 and STAG2 in diverse cancer contexts. eLife 6 (2017)
Sara Sdelci, Charles-Hugues Lardeau, Cynthia Tallant, Freya Klepsch, Björn Klaiber, James Bennett, Philipp Rathert, Michael Schuster, Thomas Penz, Oleg Fedorov, Giulio Superti-Furga, Christoph Bock, Johannes Zuber, Kilian V M Huber, Stefan Knapp, Susanne Müller, Stefan Kubicek
Mapping the chemical chromatin reactivation landscape identifies BRD4-TAF1 cross-talk. Nature chemical biology 12 (7) (2016)

Johannes Zuber.css-eqlu8i{font-size:small;padding-left:4px;} (J Zuber)

Publication Activity (10 Years)

Top Topics

Top Venues

Johannes Zuber (J Zuber)